Meralys Duo

Xylometazoline Hydrochloride, the active ingredient in Meralys Duo, is an alpha‑adrenergic agonist presented as a nasal spray for intranasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children when appropriate.

GNH USA supplies Meralys Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions, including hospitals and procurement teams globally throughout.

Xylometazoline Hydrochloride is used as a topical nasal decongestant to relieve swelling of the nasal mucosa in several common conditions.

- Common cold nasal congestion: reduces swelling and improves airflow during acute upper respiratory infections. - Sinusitis-related congestion: alleviates nasal blockage associated with sinus inflammation. - Allergic rhinitis: diminishes nasal swelling caused by allergen exposure.

Adverse reactions may occur with intranasal use of Xylometazoline Hydrochloride.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing. - Headache. - Altered taste or bitter taste. - Mild epistaxis.

Serious or Rare Side Effects: - Severe nasal bleeding. - Allergic reactions such as rash, itching, or swelling. - Hypertension or elevated blood pressure. - Tachycardia or rapid heart rate. - Ocular irritation if the spray contacts the eyes. - Rebound congestion with prolonged use.

Use Meralys Duo with awareness of specific safety considerations.

- Limit duration of use: avoid continuous use beyond 3‑5 days to prevent rebound congestion. - Caution in hypertension: monitor blood pressure if the product is used in patients with high blood pressure. - Age restriction: do not use in children under 6 years unless directed by a healthcare professional. - Avoid concurrent nasal decongestants: do not combine with other topical decongestants to reduce risk of excessive vasoconstriction. - Pregnancy and breastfeeding: consult a healthcare professional before use, as safety data are limited. - Store below 25°C: keep in the original container, protect from moisture and heat.

Xylometazoline Hydrochloride may interact with other medicines.

Major Interactions (Avoid): - Other topical nasal decongestants (e.g., phenylephrine) – risk of excessive vasoconstriction. - Monoamine oxidase inhibitors (MAOIs) – may potentiate hypertensive response.

Moderate Interactions (Monitor Closely):\n- Oral antihypertensives – possible additive blood‑pressure‑lowering effect. - Beta‑blockers – monitor for increased cardiovascular effects. - Tricyclic antidepressants – watch for blood‑pressure changes. - Nasal corticosteroids – assess for local irritation when used together.